UBX: Unity Biotechnology, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.19
Enterprise Value ($M) 8.61
Book Value ($M) 6.49
Book Value / Share 0.38
Price / Book 2.49
NCAV ($M) -6.90
NCAV / Share -0.41
Price / NCAV -2.35

Profitability (mra)
Return on Invested Capital (ROIC) -0.87
Return on Assets (ROA) -0.44
Return on Equity (ROE) -1.08

Liquidity (mrq)
Quick Ratio 2.62
Current Ratio 2.62

Balance Sheet (mrq) ($M)
Current Assets 24.27
Assets 37.66
Liabilities 31.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -28.47
Net Income -25.99
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -20.86
Cash from Investing 8.56
Cash from Financing 0.08

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Alyeska Investment Group, L.P. 9.99 -0.53

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 13,364 54,749 24.41
2025-04-10 20,296 53,786 37.73
2025-04-09 41,019 92,814 44.19
2025-04-08 75,688 209,284 36.17
2025-04-07 38,608 102,099 37.81

(click for more detail)

Similar Companies
TWST – Twist Bioscience Corporation TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc. UTHR – United Therapeutics Corporation
VERV – Verve Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io